TFX · NYSE
Teleflex Incorporated
$151.80 +1.76 (+1.17%)
Company overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, blood pressure measurement, and blood sample withdrawal through a single puncture site. Teleflex also offers interventional products, including various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products used by interventional cardiologists, radiologists, and vascular surgeons, as well as Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure device, and Arrow Oncontrol devices.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $6.4B
- Employees
- 14,100
- Headquarters
- Wayne, PA
- Website
- teleflex.com
- CEO
- Stuart A. Randle
- Listed
- March 17, 1980
- P/E
- -6.66
- Dividend yield
- 0.99%
Company financials
- Revenue
- $2.8B
- Gross profit
- $1.5B
- Operating income
- $182M
- EBITDA
- -$88.5M
- Net income
- -$1B
- EPS
- -$22.80
- Total assets
- $6.8B
- Total debt
- $171M
- Gross margin
- 53.27%
- Net margin
- -35.89%
- Earnings yield
- -15.02%
Showing FY 2025
TFX
1D
NYSE
O141.39H150.04L141.39C150.04+10.09 (+7.21%)Vol1.12M
News